Introduction to Testing for Drugs of Abuse
Shipping & Delivery
Our Delivery Time Frames Explained
2-4 Working Days: Available in-stock
14-28 Working Days: On Backorder
Will Deliver When Available: On Pre-Order or Reprinting
We ship your order once all items have arrived at our warehouse and are processed. Need those 2-4 day shipping items sooner? Just place a separate order for them!
Product details
- ISBN 9781119794059
- Weight: 340g
- Dimensions: 152 x 229mm
- Publication Date: 05 May 2022
- Publisher: John Wiley & Sons Inc
- Publication City/Country: US
- Product Form: Paperback
An Introduction to Testing for Drugs of Abuse
An Introduction to Testing for Drugs of Abuse presents a distilled set of facts about the major drugs of abuse that are encountered in clinical practice. Individual chapters highlight the similarities in chemical structure, mechanism of action, and physiologic effects of each drug group, as well as their metabolism, therapeutic uses and potential for misuse or abuse. Special attention is given to the testing process, with an emphasis on interpretation of test results.
Informative and entertaining cases appear at the end of each chapter. These cases illustrate the many situations in which drug testing is performed for medical, legal and employment purposes.
Written in clear, concise language, this book provides practical guidance to pathologists, clinical chemists and technologists who are responsible for reporting and interpreting the results of drug analyses. It will be especially useful to residents and students who are learning about toxicology for the first time. Clinical practitioners – doctors, nurses, pharmacists and other health care professionals – will find the information they need to order and interpret drug tests accurately.
For more information watch the trailer here: https://players.brightcove.net/4931690914001/B1xdbomRDl_default/index.html?videoId=6310075842112
About the Author
William E. Schreiber is a Professor in the Department of Pathology and Laboratory Medicine at The University of British Columbia and Clinical Director of Chemistry at LifeLabs. Previously, he was a consultant pathologist at Vancouver General Hospital and medical director of the British Columbia Provincial Toxicology Centre. He is a past president of the American Society for Clinical Pathology.
